| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.2B | $0.1B | $0.2B | $0.2B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $2.09 | $3.29 | $2.58 | $2.97 | $3.13 | $0.56 | $0.67 | $0.76 |
| EPS (Diluted) | $2.07 | $3.27 | $2.56 | $2.95 | $3.12 | $0.56 | $0.67 | $0.76 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $26.8B | $18.0B | $17.4B | $17.0B | $16.8B | $14.9B | $13.4B | $12.9B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.1B | $1.1B | $0.8B | $0.6B | $1.9B | $0.6B | $0.4B | $0.6B |
| Total Liabilities | $22.9B | $15.4B | $15.1B | $14.9B | $14.6B | $12.8B | $11.3B | $10.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $3.9B | $2.7B | $2.3B | $2.1B | $2.2B | $2.1B | $2.1B | $2.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.1B | $0.1B | $0.6B | $0.1B | $0.1B | $0.2B | $0.1B |
| Investing Cash Flow | $-0.7B | $-0.3B | $-0.1B | $-2.0B | $-0.7B | $-1.3B | $-0.5B | $-0.5B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.4B | $0.5B | $0.1B | $0.2B | $1.8B | $1.4B | $0.2B | $0.7B |